Polymyxin B Injection, Powder, Lyophilized, For Solution
Product Images NDC 72266-249

This is a description of a medication called Polymyxin B for Injection, USP. The package contains 10 sterile vials that are lyophilized. Each vial has Polymyxin B Sulfate, equivalent to 500,000 Polymyxin B units. The medication is meant for intramuscular, intravenous, and/or intrathecal administration under the supervision of a healthcare professional. A warning is provided that the drug may be neuro- and nephrotoxic, and it must be administered to hospitalized patients only. There are dosage restrictions not to exceed 25,000 units per kg per day. The medication should be stored between 20-25° C before reconstitution, and refrigerated between 2-8° C after reconstitution, and any unused portion should be discarded after 72 hours. The manufacturer is Fosun Pharma USA Inc. and the code number is AP/DRUGS/103/97.*

This is a description of a drug called Polymyxin B for injection, USP. The drug comes in vials containing 500,000 units and is intended for hospital use only. It is administered through intramuscular, intravenous, or intrathecal routes. The drug is sterile and should be protected from light. Dosages should not exceed 25,000 units per kg per day as the drug can be neuro- and nephrotoxic. Before reconstitution, it should be stored between 20-25°C and after reconstitution, it should be stored under refrigeration, and any unused portion should be discarded after 72 hours. The drug is distributed by Fosun Pharma USA Inc. from Princeton, NJ, and is made in India.*

This text contains chemical names and formulas, specifically Polymyxin B, with variations indicated by R=CH and R=H. This may be applicable for individuals in the field of pharmacy or chemistry.*